scholarly article | Q13442814 |
P50 | author | Stefan M. Pfister | Q39183179 |
Marc Remke | Q43153350 | ||
Marcel Kool | Q90637389 | ||
Paul A Northcott | Q91826566 | ||
P2093 | author name string | J Lee | |
M D Taylor | |||
K Gandhi | |||
R C Castellino | |||
M C Buss | |||
M J Schniederjan | |||
P2860 | cites work | Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalization | Q22010658 |
The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop | Q24297633 | ||
Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner | Q24336721 | ||
PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints | Q24527393 | ||
p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation | Q24596239 | ||
Molecular subgroups of medulloblastoma: the current consensus | Q24615271 | ||
Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy | Q24651380 | ||
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 | Q27642888 | ||
Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. | Q27851485 | ||
Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23 | Q28218453 | ||
Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity | Q28218469 | ||
Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci | Q28236937 | ||
Subgroup-specific structural variation across 1,000 medulloblastoma genomes | Q28271811 | ||
Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase | Q28283888 | ||
Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma | Q28284093 | ||
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome | Q28298987 | ||
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer | Q28388006 | ||
Altered neural cell fates and medulloblastoma in mouse patched mutants | Q28588056 | ||
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations | Q30040534 | ||
Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma | Q30156001 | ||
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors. | Q33209208 | ||
Overexpressed TP73 induces apoptosis in medulloblastoma | Q33290650 | ||
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features | Q33366431 | ||
Ablation of key oncogenic pathways by RITA-reactivated p53 is required for efficient apoptosis | Q33438165 | ||
Targeting p53 for Novel Anticancer Therapy | Q33655329 | ||
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas | Q34167499 | ||
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma | Q34215755 | ||
G-protein-coupled receptors and cancer. | Q34606002 | ||
G protein-coupled receptor kinase 5 phosphorylation of hip regulates internalization of the chemokine receptor CXCR4 | Q35166206 | ||
Clonal selection drives genetic divergence of metastatic medulloblastoma | Q35784926 | ||
HDM2 promotes WIP1-mediated medulloblastoma growth. | Q35845228 | ||
Functional genomics identifies drivers of medulloblastoma dissemination | Q36296016 | ||
Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D | Q36326949 | ||
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups | Q36460209 | ||
Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables | Q36476670 | ||
Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint | Q36841814 | ||
Medulloblastoma comprises four distinct molecular variants | Q36920479 | ||
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. | Q37089440 | ||
Genetic variants and mutations of PPM1D control the response to DNA damage. | Q37396919 | ||
A review on CXCR4/CXCL12 axis in oncology: no place to hide. | Q38017493 | ||
Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91. | Q39875833 | ||
Intrinsic kinase activity and SQ/TQ domain of Chk2 kinase as well as N-terminal domain of Wip1 phosphatase are required for regulation of Chk2 by Wip1. | Q40263011 | ||
Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results | Q40636357 | ||
c-Myc enhances sonic hedgehog-induced medulloblastoma formation from nestin-expressing neural progenitors in mice | Q41589752 | ||
CXCR4 activation defines a new subgroup of Sonic hedgehog-driven medulloblastoma | Q41760694 | ||
RETRACTED ARTICLE: Localized synovial hypertrophy in the anteromedial compartment of the osteoarthritic knee | Q42425290 | ||
WIP1 phosphatase modulates the Hedgehog signaling by enhancing GLI1 function. | Q42676343 | ||
SDF-1 alpha induces chemotaxis and enhances Sonic hedgehog-induced proliferation of cerebellar granule cells. | Q43700208 | ||
Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients | Q44608794 | ||
p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease | Q44635070 | ||
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial | Q45120061 | ||
Medulloblastoma: freedom from relapse longer than 8 years--a therapeutic cure? | Q46648311 | ||
Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies | Q46853172 | ||
Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas. | Q48506060 | ||
Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood | Q48948841 | ||
PPM1D is a potential target for 17q gain in neuroblastoma | Q52828743 | ||
Surveillance scanning of children with medulloblastoma. | Q52883048 | ||
Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients. | Q53286039 | ||
Wip1 phosphatase regulates p53-dependent apoptosis of stem cells and tumorigenesis in the mouse intestine. | Q53322778 | ||
Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice. | Q53346673 | ||
The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis. | Q53595739 | ||
Medulloblastoma: a potpourri of distinct entities. | Q55462236 | ||
Adult medulloblastoma comprises three major molecular variants. | Q55463035 | ||
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis. | Q55468802 | ||
c-Myc promoter activation in medulloblastoma. | Q55472620 | ||
Wip1 Phosphatase Modulates ATM-Dependent Signaling Pathways | Q61849111 | ||
The role of receptor kinases and arrestins in G protein-coupled receptor regulation | Q74578170 | ||
Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival | Q81325774 | ||
Medulloblastoma | Q84749666 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | medulloblastoma | Q1333608 |
P304 | page(s) | 1126-1140 | |
P577 | publication date | 2014-03-17 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants | |
P478 | volume | 34 |